Author Correction: Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial. Bégin P, Callum J, Jamula E, Cook R, Heddle NM, Tinmouth A, Zeller MP, Beaudoin-Bussières G, Amorim L, Bazin R et al.. 2022. Author Correction: Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial.. Nat Med. 28(1):212. Read more about Author Correction: Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial. Google Scholar
Metabolic and Immune Markers for Precise Monitoring of COVID-19 Severity and Treatment. Rendeiro AF, Vorkas CKyriakos, Krumsiek J, Singh HK, Kapadia SN, Cappelli LVincenzo, Cacciapuoti MTeresa, Inghirami G, Elemento O, Salvatore M. 2021. Metabolic and Immune Markers for Precise Monitoring of COVID-19 Severity and Treatment.. Front Immunol. 12:809937. Read more about Metabolic and Immune Markers for Precise Monitoring of COVID-19 Severity and Treatment. Google Scholar
Reactive arthritis following COVID-19 vaccination with BNT162b2. Lebowitz E, Kim JS, Magro C. 2022. Reactive arthritis following COVID-19 vaccination with BNT162b2.. JAAD Case Rep. 24:108-111. Read more about Reactive arthritis following COVID-19 vaccination with BNT162b2. Google Scholar
Toxic epidermal necrolysis-like linear IgA bullous dermatosis after third Moderna COVID-19 vaccine in the setting of oral terbinafine. Han J, Russo G, Stratman S, Psomadakis CE, Rigo R, Owji S, Luu Y, Mubasher A, Gonzalez BRubio, Ungar J et al.. 2022. Toxic epidermal necrolysis-like linear IgA bullous dermatosis after third Moderna COVID-19 vaccine in the setting of oral terbinafine.. JAAD Case Rep. 24:101-104. Read more about Toxic epidermal necrolysis-like linear IgA bullous dermatosis after third Moderna COVID-19 vaccine in the setting of oral terbinafine. Google Scholar
The spectrum of complement pathway activation is integral to the pathogenesis of severe COVID-19. Magro C, Nuovo G. 2022. The spectrum of complement pathway activation is integral to the pathogenesis of severe COVID-19.. Brain. 145(11):e115-e117. Read more about The spectrum of complement pathway activation is integral to the pathogenesis of severe COVID-19. Google Scholar
Immunogenicity of COVID-19 mRNA vaccines in patients with acute myeloid leukemia and myelodysplastic syndrome. Helfgott DC, Racine-Brzostek S, Short KJ, Zhao Z, Christos P, Nino I, Niu T, Contreras J, Ritchie EK, Desai P et al.. 2023. Immunogenicity of COVID-19 mRNA vaccines in patients with acute myeloid leukemia and myelodysplastic syndrome.. Leuk Lymphoma. 64(3):662-670. Read more about Immunogenicity of COVID-19 mRNA vaccines in patients with acute myeloid leukemia and myelodysplastic syndrome. Google Scholar
Longitudinal antibody response kinetics following SARS-CoV-2 messenger RNA vaccination in pregnant and nonpregnant persons. Prabhu M, Yang YJ, Johnston CD, Murphy EA, Ketas TJ, Díaz-Tapia R, Jurkiewicz M, Racine-Brzostek S, Mohammed I, Sukhu AC et al.. 2023. Longitudinal antibody response kinetics following SARS-CoV-2 messenger RNA vaccination in pregnant and nonpregnant persons.. Am J Obstet Gynecol MFM. 5(2):100796. Read more about Longitudinal antibody response kinetics following SARS-CoV-2 messenger RNA vaccination in pregnant and nonpregnant persons. Google Scholar
SARS-CoV-2 Continuous Genetic Divergence and Changes in Multiplex RT-PCR Detection Pattern on Positive Retesting Median 150 Days after Initial Infection. Liu D, Rodriguez GD, Zhou H-Y, Cheng Y-X, Li X, Tang W, Prasad N, Chen C-C, Singh V, Konadu E et al.. 2022. SARS-CoV-2 Continuous Genetic Divergence and Changes in Multiplex RT-PCR Detection Pattern on Positive Retesting Median 150 Days after Initial Infection.. Int J Mol Sci. 23(11) Read more about SARS-CoV-2 Continuous Genetic Divergence and Changes in Multiplex RT-PCR Detection Pattern on Positive Retesting Median 150 Days after Initial Infection. Google Scholar
Prevalence and Mechanisms of Mucus Accumulation in COVID-19 Lung Disease. Kato T, Asakura T, Edwards CE, Dang H, Mikami Y, Okuda K, Chen G, Sun L, Gilmore RC, Hawkins P et al.. 2022. Prevalence and Mechanisms of Mucus Accumulation in COVID-19 Lung Disease.. Am J Respir Crit Care Med. 206(11):1336-1352. Read more about Prevalence and Mechanisms of Mucus Accumulation in COVID-19 Lung Disease. Google Scholar
Placental pathology in women vaccinated and unvaccinated against SARS-CoV-2. Smithgall MC, Murphy EA, Schatz-Siemers N, Matrai C, Tu J, Baergen RN, Yang YJ. 2022. Placental pathology in women vaccinated and unvaccinated against SARS-CoV-2.. Am J Obstet Gynecol. 227(5):782-784. Read more about Placental pathology in women vaccinated and unvaccinated against SARS-CoV-2. Google Scholar
